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 Clinical outcome data
 MIC distribution for wild-type populations
EUCAST interpretative criteria:  
the European  answer
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Switch to EUCAST 
breakpoints : painful ?
 Update of a multitude of documents
 Update of automated systems and LIS 
 Update and development by manufacturers of 
AST devices
 To update education of clinicians, of students, 
and laboratory personnel
 Rates of antimicrobial resistance in surveillance 
programs affected
 Impact for pharmacy
5pm-chulg – 06.11.2008 – EUCAST 
Introduction 







 Convincing arguments for switching to EUCAST 
interpretative criteria
 Technical limiting factors
 Expected role of antimicrobial testing committees & role
of SBIMC-BVIKM
 EUCAST working groups 
 Conditional deadlines 
 Diagnostic companies and AST devices
 Automated systems : ready by end-2008 to mid-2009
 ATB expression : ready by end-2008 or mid-2009
 Neosensitabs diffusion : ready by end-2008
 Disk diffusion : No deadline as long as no EUCAST 
breakpoints criteria for this method
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Evolution of antimicrobial 
breakpoints : a need
Conclusion of the Symposium of the 
SBIMC-BVIKM the 26th of May 2008
Implementation of EUCAST interpretative 
criteria for AST 
the 1st January 2010 
in all Belgian labs
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News from EUCAST 
Clinical MIC breakpoints
Antimicrobial Agents (first or revised versions)
 Penicillins (June 2008)
 Cephalosporins (March 2006)
 Carbapenems (June 2008)
 Monibactams (June 2008)
 Fluoroquinolones (June 2008)
 Aminoglycosides (June 2008)
 Glycopeptides (June 2006)
 Macrolides, Lincosamides, Streptogramins (June 2008)
 Tetracyclines (June 2008)
 Miscellaneous (June 2008)
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Other harmonisation process finalised during 
2008
 Subcommittee on antifungals
 Flu- and voriconazole (July 2008)
 Subcommittee on anaerobes
 Finalised breakpoints in 2008
 Subcommittee on antimycobacterials
 Start work in 2008
 Subcommittee on Expert Rules
 Finalised in 2008 (CMI 2009)
European disk test to be available late 2009
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European disk test based on MH-medium
&
A confluent inoculum
 MH medium for non-fastidious organisms
 MH + 5% Horse blood + b-NAD for streptococci, 
H.influenzae and fastidious organisms (+ana)
Disk strengths- most will be the same as for CLSI
QC strains, same as for CLSI and ISO document
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For end 2009, EUCAST own criteria
to match its clinical breakpoints
Development of EUCAST disk testing criteria
 for non-fastidious organisms
 Possibility to use CLSI regression analysis
 For some drug/bug combinations
 for streptococci, H.influenzae and fastidious
organisms
 New medium, everything to be done from begining
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 On the BVIKM-SBIMC website
 Some practical issues to be solved
 End 2008 - 2009
 Relevant documents from EUCAST website
 Translation according to Belgian practice
 Follow-up and news from EUCAST
 Follow-up of level of preparation in Belgium
 Slide sets
 ? Forum with questions ?
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To encourage European countries to identify or form 
NACs and to tie these to EUCAST
Role:
 To provide national expertise, consensus and education
 Consultation for EUCAST
 EUCAST link to national microbiology in European
countries
 As partners for developing, testing and implementing new 
methodology
A core group of BVIKM-SBIMC members: to appoint
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News from CLSI 
(major) update for 2009
 New look for CLSI document M100 (M2+M7)
 Revision of breakpoints according to
 PK/PD data
 Monte Carlo simulations 
 Resistance mechanisms knowledge
 Etc.
 To increase likelihood of clinical success without
further testing
 Advertising for EUCAST 
 Specifically expert rules
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News from CLSI 
(major) update for 2009
 No more disk diffusion for vancomycin and 
Staphylococci
 Cephalosporins, piperacillin/tazobactam and 
enterobacteriaceae
 New reduced breakpoints
 Carbapenems and enterobacteriaceae
 New reduced breakpoints
 Penicillin and S.pneumoniae in non-meningitis
indication
 Increased breakpoints
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2009 in Belgium 
Which criteria for AST
 CLSI 
 Interpretative criteria used in Belgian labs
 Variation in implementation of annual updates
 Discrepancies between labs
 Usually minor changes
 Not done in every lab every year
 2009 Update 
 Major changes
 Similarities with EUCAST criteria
 Automated systems (Vitek, Phoenix)
 Update: available first semester? 
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2009 in Belgium 
Which criteria for AST
 CLSI revised criteria as well as EUCAST ones
 To improve management of patients
 To increase likelihood of clinical success when a bug 
is declared Susceptible to an antimicrobial agent
 Quality Assurance in laboratories
 To implement new interpretative criteria
 Report: to mention which reference criteria were
used
 No reliable epidemiological comparisons within
Europe, even within Belgium
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 Implementation of EUCAST criteria, deadline: 
 Still 1st January 2009 
 Availability of EUCAST MIC clinical bkpts for all classes 
of antimicrobial agents
 Availability of EUCAST disk diffusion criteria (end 2009)
 SOP//CLSI except media for fastidious
 EUCAST Belgian website (end 2008-2009)
 To form EUCAST Belgian NAC
 Major revision of CLSI criteria for 2009 
 2009: difficult transition year for AST and clinical use of 
results
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